Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights

Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights

The introduction of tyrosine kinase inhibitors (TKIs) has changed the treatment paradigm of chronic myeloid leukemia (CML), leading to a dramatic improvement of the outcome of CML patients, who now have a nearly normal life expectancy and, in some selected cases, the possibility of aiming for the mo...

Full description

Bibliographic Details
Main Authors: Miriam Iezza, Sofia Cortesi, Emanuela Ottaviani, Manuela Mancini, Claudia Venturi, Cecilia Monaldi, Sara De Santis, Nicoletta Testoni, Simona Soverini, Gianantonio Rosti, Michele Cavo, Fausto Castagnetti
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cells
Subjects:
chronic myeloid leukemia
prognosis
risk assessment
genomic factors
Online Access:https://www.mdpi.com/2073-4409/12/13/1703

Internet

https://www.mdpi.com/2073-4409/12/13/1703

Similar Items